A methodologic framework for developing and selecting endpoints in clinical trials

J Rheumatol. Sep-Oct 1982;9(5):758-62.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Canada
  • Clinical Trials as Topic*
  • Humans
  • Research Design
  • Rheumatic Diseases / drug therapy
  • Rheumatology / methods*
  • Statistics as Topic
  • United States

Substances

  • Anti-Inflammatory Agents